Abstract:Importance: Pericarditis accounts for up to 5% of emergency department visits for nonischemic chest pain in North America and Western Europe. With appropriate treatment, 70% to 85% of these patients have a benign course. In acute pericarditis, the development of constrictive pericarditis (<0.5%) and pericardial tamponade (<3%) can be life-threatening. Observations: Acute pericarditis is diagnosed with presence of 2 or more of the following: sharp, pleuritic chest pain that worsens when supine (≈90%); new widespread electrocardiographic ST-segment elevation and PR depression (≈25%-50%); a new or increased pericardial effusion that is most often small (≈60%); or a pericardial friction rub (<30%). In North America and Western Europe, the most common causes of acute pericarditis are idiopathic or viral, followed by pericarditis after cardiac procedures or operations. Tuberculosis is the most common cause in endemic areas and is treated with antituberculosis therapy, with corticosteroids considered for associated constrictive pericarditis. Treatment of acute idiopathic and pericarditis after cardiac procedures or operations involves use of high-dose nonsteroidal anti-inflammatory drugs (NSAIDs), with doses tapered once chest pain has resolved and C-reactive protein level has normalized, typically over several weeks. These patients should receive a 3-month course of colchicine to relieve symptoms and reduce the risk of recurrence (37.5% vs 16.7%; absolute risk reduction, 20.8%). With a first recurrence of pericarditis, colchicine should be continued for at least 6 months. Corticosteroids are often used if pericarditis does not improve with NSAIDs and colchicine. In certain patients with multiple recurrences, which can occur for several years, interleukin 1 (IL-1) blockers have demonstrated efficacy and may be preferred to corticosteroids. Conclusions: Acute pericarditis is a common cause of nonischemic chest pain. Tuberculosis is the leading cause of pericarditis in endemic areas and is treated with antitubercular therapy. In North America and Western Europe, pericarditis is typically idiopathic, develops after a viral infection, or develops following cardiac procedures or surgery. Treatment with NSAIDs and colchicine leads to a favorable prognosis in most patients, although 15% to 30% of patients develop recurrence. Patients with multiple recurrent pericarditis can have a disease duration of several years or more, are often treated with corticosteroids, and IL-1 blockers may be used for selected patients as steroid-sparing therapy.

Pericarditis for the ages: differential outcomes and therefore age-specific therapies?

Age-stratified patterns in clinical presentation, treatment and outcomes in acute pericarditis: a retrospective cohort study

Age- and sex-based differences in patients with acute pericarditis

Diagnosis, Risk Stratification, and Treatment of Pericarditis: A Review

Recurrent pericarditis in older adults: Clinical and laboratory features and outcome

Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging

Pediatric Pericarditis: Update

Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent Pericarditis

Long-Term Data from a Longitudinal Retrospective Single-Centre Cohort

Exploring Inflammatory Markers and Risk Factors Associated with Pericarditis Development after Ablation for Atrial Fibrillation

Aetiological diagnosis in acute and recurrent pericarditis: when and how

Novel therapeutic insights into the treatment of pericarditis: Targeting the innate immune system

Incidence and Impact of Acute Pericarditis in Hospitalized Patients With COVID‐19

Pericarditis recurrence is associated with milder electrocardiographic, echocardiographic, and laboratory findings

Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis

Descriptive Study of Pericarditis Outcomes in Different Etiologies and Risk Factors: A Retrospective Record Review

Case Report: ST-Segment Elevation in a Man With Acute Pericarditis

Unraveling Recurrent Heart Inflammation: A Case Report on Myopericarditis

Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey

Adult-onset Still's disease masquerading as acute coronary syndrome: a case report and review of the literature

Novel Treatments in Refractory Recurrent Pericarditis